Nu-Life Solutions SEZC is the global developer and provider of Nu-V3 and the Nu-V3 program.
Nu-V3 is a miniaturized, wearable, non-invasive, non-pharmaceutical technology for the treatment of pain, anxiety, depression and sleeplessness and is patented and trademarked in more than 40 countries including the United States, Europe, Japan and Latin America.
The symptoms of pain, anxiety, depression and sleeplessness affect more than 1.2 billion people worldwide today, with more than 40% actively seeking treatment.
There is a well known over reliance on addictive medications that have reached epic proportions. Nu-Life intends to serve as an answer on a global scale, beginning with Nu-Life USA, Nu-Life Europe and Nu-Life Japan leading the way.
Until now, there is never been a truly effective and safe alternative to treat those suffering from pain, anxiety, depression, and sleeplessness.
Nu-V3. LIFE LIVED WELL
Company Details
- Employees
- 24
- Founded
- -
- Address
- Global Headquarters, Oo
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- nu-v3.com
- Keywords
- Wearable Medical Technology.
- HQ
- Global Headquarters
Nu-Life Solutions Questions
Nu-Life Solutions's website is nu-v3.com
Nu-Life Solutions's LinkedIn profile is https://www.linkedin.com/company/nu-life-solutions
Nu-Life Solutions has
24 employees.
View email and phone details for 24
employees at Nu-Life Solutions.
Nu-Life Solutions's industry is
Medical Equipment Manufacturing
Nu-Life Solutions's top competitors are
Emerdepot,
Bevel Workforce,
Biotechexec,
Reliant Gases,
Physio Ai,
Ipro Service,
Nu-Life Usa,
Matrix Fluidix,
National Foundation For Integrative Medicine,
Agmd Medical & Safety Suppliers & Distributors.
Nu-Life Solutions's categories are Medical Equipment Manufacturing
Nu-Life Solutions's founding year is 2010
